Back

How I manage my patients with sHTG

28 August 2026 (15:37 - 15:47)
Organised by: Logo
Congress Presentation Part of: ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG) Lipids, Metabolism Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Thomas M Stulnig

Clinic Hietzing, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Welcome and agenda
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
Triglycerides: a cardiologists’ concern – what are the risks?
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
ApoC-III targeting: a new era in triglyceride management
Doctor S. Charriere (Bron, FR)
Presentation thumbnail
Q&A, panel discussion and closing remarks

Access the full session

Session thumbnail
ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG)

The Event

Event poster

ESC Congress 2026

28 August 2026 15:37 CET
You may be interested in
thumbnail
Congress Session
One year after the ESC/ERS pulmonary hypertension Guidelines - how are they affecting our practice?
26 August 2023
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Session
Don’t forget to look right
18 May 2025
thumbnail
Congress Presentation
Floating catastrophe: an incidental finding of spontaneous floating thrombus in a non-aneurysmal descending thoracic aorta of a 69-year-old female
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources